Cargando…

P674: 2ND-LINE PONATINIB IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA (CML-CP) PATIENTS FAILING OR INTOLERANT TO 1ST-LINE 2ND GENERATION TKI THERAPY: INTERIM ANALYSIS OF THE PROSPECTIVE PONS TRIAL

Detalles Bibliográficos
Autores principales: Le Coutre, Philipp, Göthert, Joachim, Saussele, Susanne, Pelzer, Uwe, Bullinger, Lars, Elmaagacli, Ahmet, Jehn, Christian, Stegelmann, Frank, Hochhaus, Andreas, Ernst, Thomas, Burchert, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428799/
http://dx.doi.org/10.1097/01.HS9.0000969600.16797.00
_version_ 1785090556790046720
author Le Coutre, Philipp
Göthert, Joachim
Saussele, Susanne
Pelzer, Uwe
Bullinger, Lars
Elmaagacli, Ahmet
Jehn, Christian
Stegelmann, Frank
Hochhaus, Andreas
Ernst, Thomas
Burchert, Andreas
author_facet Le Coutre, Philipp
Göthert, Joachim
Saussele, Susanne
Pelzer, Uwe
Bullinger, Lars
Elmaagacli, Ahmet
Jehn, Christian
Stegelmann, Frank
Hochhaus, Andreas
Ernst, Thomas
Burchert, Andreas
author_sort Le Coutre, Philipp
collection PubMed
description
format Online
Article
Text
id pubmed-10428799
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104287992023-08-17 P674: 2ND-LINE PONATINIB IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA (CML-CP) PATIENTS FAILING OR INTOLERANT TO 1ST-LINE 2ND GENERATION TKI THERAPY: INTERIM ANALYSIS OF THE PROSPECTIVE PONS TRIAL Le Coutre, Philipp Göthert, Joachim Saussele, Susanne Pelzer, Uwe Bullinger, Lars Elmaagacli, Ahmet Jehn, Christian Stegelmann, Frank Hochhaus, Andreas Ernst, Thomas Burchert, Andreas Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428799/ http://dx.doi.org/10.1097/01.HS9.0000969600.16797.00 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Le Coutre, Philipp
Göthert, Joachim
Saussele, Susanne
Pelzer, Uwe
Bullinger, Lars
Elmaagacli, Ahmet
Jehn, Christian
Stegelmann, Frank
Hochhaus, Andreas
Ernst, Thomas
Burchert, Andreas
P674: 2ND-LINE PONATINIB IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA (CML-CP) PATIENTS FAILING OR INTOLERANT TO 1ST-LINE 2ND GENERATION TKI THERAPY: INTERIM ANALYSIS OF THE PROSPECTIVE PONS TRIAL
title P674: 2ND-LINE PONATINIB IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA (CML-CP) PATIENTS FAILING OR INTOLERANT TO 1ST-LINE 2ND GENERATION TKI THERAPY: INTERIM ANALYSIS OF THE PROSPECTIVE PONS TRIAL
title_full P674: 2ND-LINE PONATINIB IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA (CML-CP) PATIENTS FAILING OR INTOLERANT TO 1ST-LINE 2ND GENERATION TKI THERAPY: INTERIM ANALYSIS OF THE PROSPECTIVE PONS TRIAL
title_fullStr P674: 2ND-LINE PONATINIB IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA (CML-CP) PATIENTS FAILING OR INTOLERANT TO 1ST-LINE 2ND GENERATION TKI THERAPY: INTERIM ANALYSIS OF THE PROSPECTIVE PONS TRIAL
title_full_unstemmed P674: 2ND-LINE PONATINIB IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA (CML-CP) PATIENTS FAILING OR INTOLERANT TO 1ST-LINE 2ND GENERATION TKI THERAPY: INTERIM ANALYSIS OF THE PROSPECTIVE PONS TRIAL
title_short P674: 2ND-LINE PONATINIB IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA (CML-CP) PATIENTS FAILING OR INTOLERANT TO 1ST-LINE 2ND GENERATION TKI THERAPY: INTERIM ANALYSIS OF THE PROSPECTIVE PONS TRIAL
title_sort p674: 2nd-line ponatinib in chronic phase chronic myeloid leukemia (cml-cp) patients failing or intolerant to 1st-line 2nd generation tki therapy: interim analysis of the prospective pons trial
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428799/
http://dx.doi.org/10.1097/01.HS9.0000969600.16797.00
work_keys_str_mv AT lecoutrephilipp p6742ndlineponatinibinchronicphasechronicmyeloidleukemiacmlcppatientsfailingorintolerantto1stline2ndgenerationtkitherapyinterimanalysisoftheprospectiveponstrial
AT gothertjoachim p6742ndlineponatinibinchronicphasechronicmyeloidleukemiacmlcppatientsfailingorintolerantto1stline2ndgenerationtkitherapyinterimanalysisoftheprospectiveponstrial
AT sausselesusanne p6742ndlineponatinibinchronicphasechronicmyeloidleukemiacmlcppatientsfailingorintolerantto1stline2ndgenerationtkitherapyinterimanalysisoftheprospectiveponstrial
AT pelzeruwe p6742ndlineponatinibinchronicphasechronicmyeloidleukemiacmlcppatientsfailingorintolerantto1stline2ndgenerationtkitherapyinterimanalysisoftheprospectiveponstrial
AT bullingerlars p6742ndlineponatinibinchronicphasechronicmyeloidleukemiacmlcppatientsfailingorintolerantto1stline2ndgenerationtkitherapyinterimanalysisoftheprospectiveponstrial
AT elmaagacliahmet p6742ndlineponatinibinchronicphasechronicmyeloidleukemiacmlcppatientsfailingorintolerantto1stline2ndgenerationtkitherapyinterimanalysisoftheprospectiveponstrial
AT jehnchristian p6742ndlineponatinibinchronicphasechronicmyeloidleukemiacmlcppatientsfailingorintolerantto1stline2ndgenerationtkitherapyinterimanalysisoftheprospectiveponstrial
AT stegelmannfrank p6742ndlineponatinibinchronicphasechronicmyeloidleukemiacmlcppatientsfailingorintolerantto1stline2ndgenerationtkitherapyinterimanalysisoftheprospectiveponstrial
AT hochhausandreas p6742ndlineponatinibinchronicphasechronicmyeloidleukemiacmlcppatientsfailingorintolerantto1stline2ndgenerationtkitherapyinterimanalysisoftheprospectiveponstrial
AT ernstthomas p6742ndlineponatinibinchronicphasechronicmyeloidleukemiacmlcppatientsfailingorintolerantto1stline2ndgenerationtkitherapyinterimanalysisoftheprospectiveponstrial
AT burchertandreas p6742ndlineponatinibinchronicphasechronicmyeloidleukemiacmlcppatientsfailingorintolerantto1stline2ndgenerationtkitherapyinterimanalysisoftheprospectiveponstrial